Mar 1, 2021, 09:45 by

Mar 1, 2021, 09:43 by

Thermo Fisher Scientific’s latest announcement that its analytical instruments have been recognized through multiple respected industry awards.

Mar 1, 2021, 09:43 by

Ubiquigent announces it has entered an exclusive license agreement with Medivir AB to access their preclinical USP7 research program.

Mar 1, 2021, 09:43 by

Mar 1, 2021, 09:43 by

Biocept presents data showing that its Target Selector™ molecular assay kit detects mutations in up to 50% of tissue biopsy specimens, from patients diagnosed with non-small cell lung cancer, that were deemed quantity not sufficient (QNS), at the Molecular Med Tri-Con Virtual Conference.

Mar 1, 2021, 09:43 by

Mar 1, 2021, 09:43 by

Mar 1, 2021, 09:43 by

Captures ECG and heart rate as a response to treatment for heart, lung, and health problems

Mar 1, 2021, 09:43 by

Mar 1, 2021, 09:43 by

The product manager of Creative Proteomics has recently announced the fully-developed whole-genome sequencing, which can work as a powerful tool in multiple areas including diagnosis, tracking disease outbreaks, characterizing causative mutations and identifying drug-resistance genes.

Mar 1, 2021, 09:43 by

Pronalyse, a new division of Creative Proteomics, is dedicated to providing professional analysis services in biopharmaceutical development. Creative Proteomics is an integrated CRO company with more than 10 years of experience in providing impurity analysis and analytical characterization service for bioprocess development. Recently, the product manager of Pronalyse division announced protein homogeneity analysis service to speed up the drug development process.

Mar 1, 2021, 09:43 by

The UK Healthcare Pavilion has launched a new virtual platform to bring together life sciences companies, hospitals, clinics, and key organisations — helping global customers discover, connect and innovate.

Mar 1, 2021, 09:43 by

CD BioSciences, a US based supplier of clinical development services, has announced to provide global scientists with early phase clinical services, aiming to accelerate their drug development projects.

Mar 1, 2021, 09:43 by

Mar 1, 2021, 09:43 by

Mar 1, 2021, 09:43 by

Feb 26, 2021, 01:00 by User Not Found

Clinical Research News | A survey of how rehabilitation is helping patients with severe COVID-19, what COVID-19 means for Down Syndrome patients, and the timing of vaccines. Plus: real world data for COVID-19 vaccination, intranasal COVID-19 vaccine, more.

Feb 25, 2021, 01:00 by User Not Found

Clinical Research News | Deployment of clinical trials for Pfizer’s COVID-19 vaccine candidate was the fastest in the company’s history, and possibly industry-wide. Six weeks after the decision was made to run the combined phase 1/2/3 study, the first patient was enrolled and, six months later, it had all the safety and efficacy data needed to request Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) to start getting the vaccine into people’s arms.

Feb 23, 2021, 01:00 by User Not Found

Clinical Research News | The pandemic has had some “silver linings” for clinical studies and the overall U.S. healthcare system, according to speakers discussing adaptive trial design at the recent COVID-19 and Cancer virtual meeting of the American Association for Cancer Research (AACR). We can’t go back to business as usual.

Feb 19, 2021, 01:00 by User Not Found

Clinical Research News | Europe’s vaccination priority for the mentally ill, fighting “vaccine nationalism”, how the humidity inside the face mask can help. Plus: trials of remdesivir in pregnant women, EMA releases guidance on trials during pandemic, and seeking priority vaccines for cancer patients, diabetes sufferers.